Associate Director, Precision Medicine and Digital Health

at  Takeda Pharmaceutical

By clicking the “Apply” button, I understand that my employment application process with Takeda will commence and that the information I provide in my application will be processed in line with Takeda’s Privacy Notice and Terms of Use. I further attest that all information I submit in my employment application is true to the best of my knowledge.

ACCOUNTABILITIES:

• Responsible for developing and leading the global regulatory strategies for precision medicine and digital health efforts for assigned programs.
• Identifies regulatory requirements and provides regulatory guidance, and expertise to global development team on the assigned project(s) of responsibility.
• Identify potential regulatory risks and develop mitigation strategies to address them.
• Ensures therapeutic asset’s global regulatory plans effectively accommodate appropriate precision medicine approaches by effectively integrating drug and diagnostic regulatory and submission plans including HA engagement plans and mitigation strategies
• Ensures line management and key stakeholders are apprised of developments that may impact regulatory success, exercising sound judgement and communicating in a professional and timely manner. Demonstrates ability to anticipate risks and responsible for developing solutions to identified risks and discussing with management; understands probabilities of technical success for the solutions.
• Effectively represent the Global Regulatory Affairs (GRA) function in senior level interactions at internal governance technical review committees, key global health authority meetings and external partners.
• Participates with influence in or leads departmental and cross-functional task-forces and initiatives. Influence cross-functional colleagues within the therapeutic area, across GRA and across the enterprise.
• Provide training to cross-functional teams to enhance their understanding of regulatory requirements and processes.
• Helps implement a culture of continuous improvement to improve regulatory processes, and drive the adoption of innovation and best practices within the regulatory function.
• Provide regulatory strategy support to diligence for licensing opportunities as appropriate
• Monitor and anticipate trends that impact both the regulatory and access environments to strengthen product development plan(s) and adopt regulatory strategies in a timely manner.

EDUCATION & COMPETENCIES (TECHNICAL AND BEHAVIORAL):

• Bachelor’s Degree, scientific discipline strongly preferred
• Advanced degree in a scientific discipline (PhD., M.D., PharmD, MS) strongly preferred
• A minimum of 3-5 years of experience in regulatory affairs. Pharmaceutical industry experience strongly preferred.
• Proven track record in developing and managing regulatory strategies for digital health products, and/or diagnostics, and precision medicine.
• Expert knowledge of device development, registration and maintenance regulations with experience in championing innovation in technical areas.
• Comprehensive understanding of biomarker strategies and implications for drug development.
• Demonstrated track record of successful interactions with FDA, EMA, Notified Bodies, and other global health authorities specifically related to Device submissions (ie, IND, SRDs, CTA, IMPD, BLA, MAA, NDA, 510K, CE Mark submissions and their amendments/supplements).
• Understanding of scientific principles and device regulatory requirements relevant to global drug development and post-market support, including recent EU MDR and IVDR.
• Understands and interprets scientific data as it relates to regulatory requirements and strategy for assigned projects and provides knowledge and expertise to guide team in established and building appropriate global regulatory strategy.

• Provides strategic and tactical advice to teams for the delivery of global regulatory strategies to support development and commercialization of biomarkers, diagnostic tests, devices and digital health tools to enhance the value of our products across therapeutic areas
• Establish effective collaborations with the various groups involved in the development and commercialization of biomarkers, diagnostic tests and digital tools to ensure goals/objectives are met.